Form 4: ALHC CMO Sells Shares for Tax Obligations

Alignment Healthcare's Chief Medical Officer, Hyong Kim, sold 12,694 shares of common stock to cover tax withholding obligations related to performance share unit vesting.

Summary

• Hyong Kim, Chief Medical Officer of Alignment Healthcare, Inc. (ALHC), reported the sale of 12,694 shares of common stock.
• The sales occurred on December 29, 2025.
• The transactions were non-discretionary, executed solely to cover tax withholding obligations associated with the vesting of performance share units.
• Specifically, 11,998 shares were sold at a weighted-average price of $18.7056 per share, with prices ranging from $18.23 to $19.225.
• An additional 696 shares were sold at a weighted-average price of $19.3818 per share, with prices ranging from $19.23 to $19.51.
• Following these transactions, Hyong Kim beneficially owns 349,639 shares of Alignment Healthcare common stock.

Sentiment

Score: 5

Explanation: The transaction is a routine, non-discretionary sale to cover tax obligations upon the vesting of performance share units. It is a neutral event, neither significantly positive nor negative for the company's outlook.

Positives

• The underlying event, vesting of performance share units, indicates the achievement of performance milestones or continued employment, which is generally positive for the company and its executives.
• The sale was non-discretionary, solely for tax purposes, not an indication of a lack of confidence in the company.

Negatives

• A reduction in direct beneficial ownership, even if for tax purposes, slightly decreases the executive's direct equity stake.

Future Outlook

No forward-looking statements or guidance are provided in this Form 4 filing.

Industry Context

This Form 4 filing reports a routine insider transaction for tax purposes, which is common across all industries when executives receive equity compensation. It does not provide specific insights into broader industry trends or competitive positioning for Alignment Healthcare.

Comparison to Industry Standards

• The reported transaction is a standard practice for executives receiving equity compensation, where a portion of vested shares is sold to cover tax liabilities. This is consistent with compensation structures observed in healthcare and other sectors, and does not indicate any deviation from global benchmarks or specific comparable company practices.

Related Party Transactions

• The transaction involves an executive and the company's stock, which is a related party transaction, but it is a standard compensation-related event and not a unique disclosure of a new related party dealing.

Stakeholder Impact

• Shareholders: Minimal direct impact. The sale is routine for tax purposes and does not signal a change in management's confidence. The total number of shares sold (12,694) is a small fraction of the company's outstanding shares and the executive's total holdings.
• Employees: No direct impact mentioned.
• Customers: No direct impact mentioned.
• Suppliers: No direct impact mentioned.
• Creditors: No direct impact mentioned.

Key Dates

Recommendation

This Form 4 filing details a routine, non-discretionary sale of shares by a Chief Medical Officer to cover tax obligations associated with the vesting of performance share units. Such transactions are common and do not typically reflect a change in the executive's confidence in the company or its future prospects. The volume of shares sold is relatively small compared to the executive's remaining holdings and the company's overall market capitalization. Therefore, this specific filing provides no new material information that would warrant a change in investment thesis, leading to a 'hold' recommendation based solely on this report.

Keywords

Alignment Healthcare, ALHC, Hyong Kim, Chief Medical Officer, Form 4, Insider Trading, Stock Sale, Tax Withholding, Performance Share Units, Equity Compensation